• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-12

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, more accurately reproducing the cellular heterogeneity and drug response variability of primary tumors. The approach enables detailed investigation of tumor–microenvironment interactions and supports personalized drug screening for improved therapeutic strategies.

• Ruthenium Red as a Ca2+ Transport Inhibitor in Mechanotransd

  2026-05-12

  Ruthenium Red uniquely empowers researchers to dissect cytoskeleton-dependent calcium signaling and mechanotransduction, offering robust inhibition of mitochondrial and sarcoplasmic reticulum Ca2+ transport. This article provides actionable workflow guidance, troubleshooting strategies, and a direct translation of recent breakthroughs in mechanical stress-induced autophagy for optimized calcium signaling research.

• Belinostat (PXD101): Reliable HDAC Inhibition for Cancer Ass

  2026-05-11

  This article offers scenario-driven insights for optimizing cell viability and proliferation assays using Belinostat (PXD101), SKU A4096. Emphasizing evidence-based protocols and practical troubleshooting, it guides researchers in achieving reproducible, quantitative results in epigenetic cancer therapy studies. Practical comparisons and workflow tips highlight the advantages of Belinostat (PXD101) for rigorous biomedical research.

• Microfluidic Peptide/mRNA Complexes Enable Efficient Pulmona

  2026-05-11

  This study introduces a microfluidic mixing approach to create robust peptide/mRNA complexes suitable for pulmonary delivery by nebulisation. The findings demonstrate preserved transfection efficiency post-nebulisation, suggesting significant potential for clinical applications in lung-targeted mRNA therapeutics.

• Heparin Sodium in Thrombosis Research: Protocols & Innovatio

  2026-05-10

  Heparin sodium is a benchmark glycosaminoglycan anticoagulant for modeling the blood coagulation pathway and optimizing anti-factor Xa activity assays. This article details practical workflows, highlights protocol advancements, and translates new nanovesicle biology into actionable strategies—enabling researchers to maximize reproducibility and innovation in thrombosis studies.

• Plant Exosome-Like Nanovesicles Restore Sertoli Cell Functio

  2026-05-09

  This study demonstrates that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) are taken up by Sertoli cells via heparan sulfate proteoglycans, delivering miR159b-3p to alleviate cyclophosphamide-induced cell cycle arrest. The findings open new avenues for cell-targeted therapies in testicular injury and highlight the interplay between nanovesicle uptake and glycosaminoglycan biology.

• Allosteric PDK4 Inhibitors: Advancing Metabolic Disease Rese

  2026-05-08

  This study introduces a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, notably compound 8c, with high in vitro potency and promising efficacy in metabolic, allergic, and cancer models. The findings highlight the therapeutic potential of PDK4 modulation for metabolic disease intervention and provide a new scaffold for drug development.

• MDV3100 (Enzalutamide): Experimental Workflows in Prostate C

  2026-05-08

  Unlock the full potential of MDV3100 (Enzalutamide) with advanced, evidence-based workflows for dissecting androgen receptor signaling and overcoming resistance in prostate cancer research. This guide details stepwise protocols, key senescence insights, and troubleshooting strategies that maximize data quality—making it essential for any lab investigating castration-resistant prostate cancer.

• PEDV Rewires IMPDH-Dependent Nucleotide Synthesis for Replic

  2026-05-07

  This study uncovers how porcine epidemic diarrhea virus (PEDV) manipulates host IMPDH-dependent guanosine biosynthesis to promote its replication in cell models. By demonstrating that both genetic and pharmacological inhibition of IMPDH—specifically with Merimepodib (VX-497)—markedly suppresses PEDV replication, the research establishes IMPDH as a promising host-directed antiviral target for veterinary coronaviruses.

• Erastin (SKU B1524): Reliable Ferroptosis Inducer for Cancer

  2026-05-07

  Discover how Erastin (SKU B1524) addresses core laboratory challenges in ferroptosis research, from protocol optimization to data interpretation and vendor selection. This article delivers actionable, evidence-based guidance for scientists seeking reproducible and selective induction of iron-dependent, non-apoptotic cell death in RAS- and BRAF-mutant tumor models.

• Dabigatran (Pradaxa): Optimizing Thrombin Inhibition Workflo

  2026-05-06

  Dabigatran (Pradaxa) stands at the forefront of direct thrombin inhibition, enabling robust, reproducible results in coagulation assays and translational anticoagulation research. This article dissects experimental workflows, protocol optimizations, and troubleshooting strategies that leverage APExBIO’s Dabigatran for both mechanistic and applied studies.

• Nanoplastics and Cadmium Co-exposure Triggers Intestinal Apo

  2026-05-06

  This study reveals that co-exposure to polystyrene nanoplastics and cadmium induces apoptosis in intestinal cells through activation of the IP3R/Ca2+/STAT3 pathway. Mechanistic interrogation using calcium chelation and pathway inhibitors highlights a pivotal regulatory axis, informing environmental risk assessments and suggesting practical tools for dissecting calcium-dependent cell death.

• Technical Use of Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-05

  The Hoechst 33342/PI Double Staining Kit provides a fluorescence-based approach to discriminate between apoptosis and necrosis in cultured cells, supporting rapid, microscopy-driven cell death analysis. It is suitable for basic research applications but is not intended for diagnostic or medical use.

• Dabigatran Etexilate: Direct Thrombin Inhibitor in Translati

  2026-05-05

  Dabigatran etexilate enables precise, reproducible modulation of the coagulation cascade in both in vitro and in vivo models. Explore how its high selectivity, oral prodrug form, and robust performance transform experimental designs for anticoagulant and atrial fibrillation research.

• Deferasirox: Advanced Iron Chelation and Ferroptosis Modulat

  2026-05-04

  Explore how Deferasirox, a leading oral iron chelator, advances both iron overload therapy and cancer research by uniquely targeting ferroptosis resistance. This article provides a deep dive into recent molecular discoveries, practical assay guidance, and critical comparisons to existing approaches.

16168 records 1/1078 page Next 12345 下5页 Last page